After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, RPRX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Royalty Pharma plc is $12.32B. A total of 2.83 million shares were traded on the day, compared to an average of 2.45M shares.
In the most recent transaction, RIGGS RORY B sold 235,200 shares of RPRX for 28.52 per share on Jan 02 ’24. After the transaction, the Director now owns 254,899 company shares. In a previous transaction on Jan 03 ’24, RIGGS RORY B sold 199,098 shares at 27.79 per share. RPRX shares that Director owns now total 55,801.
Among the insiders who sold shares, RIGGS RORY B disposed of 35,702 shares on Jan 04 ’24 at a per-share price of $27.55. This resulted in the Director holding 20,099 shares of RPRX after the transaction. In another insider transaction, Avara Management Ltd sold 65,803 shares at $28.04 per share on Dec 29 ’23. Company shares held by the 10% Owner now total 2,477,520.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Royalty Pharma plc pays an annual dividend of $0.83, resulting in a dividend yield of 3.02%, and it has a price to earnings (P/E) ratio of 18.29. RPRX’s most recent ex-dividend date was 8/16/2024 when it declared a $0.21 quarterly dividend that was paid in cash on 9/13/2024. Previously, the company paid the dividend on 6/14/2024 with an ex-dividend date of 5/16/2024. The RPRX stock dividend was $0.21 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, RPRX has a high of $31.66 and a low of $25.20.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. RPRX’s latest balance sheet shows that the firm has $2.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.10B in debt and $171.25M in liabilities at the time. Its Book Value Per Share was $14.42, while its Total Shareholder’s Equity was $10.25B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPRX is Buy with a score of 4.50.
